Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  3/5/2018
Albany Medical Center
mi
from
Albany, NY
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 3/5/2018
Albany Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  3/5/2018
Children's Hospital
mi
from
Buffalo, NY
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 3/5/2018
Children's Hospital
mi
from
Buffalo, NY
Click here to add this to my saved trials
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  3/5/2018
Schneider Children's Hospital
mi
from
New Hyde Park, NY
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 3/5/2018
Schneider Children's Hospital
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  3/5/2018
Strong Memorial Hospital
mi
from
Rochester, NY
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 3/5/2018
Strong Memorial Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  3/5/2018
Univesity Medical Center
mi
from
Stony Brook, NY
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 3/5/2018
Univesity Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  3/5/2018
SUNY Upstate Medical Center
mi
from
Syracuse, NY
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 3/5/2018
SUNY Upstate Medical Center
mi
from
Syracuse, NY
Click here to add this to my saved trials
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  3/5/2018
Childrens Hospital Westchester Medical Center
mi
from
Valhalla, NY
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 3/5/2018
Childrens Hospital Westchester Medical Center
mi
from
Valhalla, NY
Click here to add this to my saved trials
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  3/5/2018
Lewis H Walker CF Pulmonary Center
mi
from
Akron, OH
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 3/5/2018
Lewis H Walker CF Pulmonary Center
mi
from
Akron, OH
Click here to add this to my saved trials
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  3/5/2018
Lewis H Walker Cystic Fibrosis Center Division of Pulmonary
mi
from
Akron, OH
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 3/5/2018
Lewis H Walker Cystic Fibrosis Center Division of Pulmonary
mi
from
Akron, OH
Click here to add this to my saved trials
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  3/5/2018
St. Christopher's Hospital for Children
mi
from
Philadelphia, PA
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 3/5/2018
St. Christopher's Hospital for Children
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  3/5/2018
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 3/5/2018
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  3/5/2018
Mountain State University
mi
from
Morgantown, WV
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 3/5/2018
Mountain State University
mi
from
Morgantown, WV
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Glenview, IL
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Glenview, IL
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Las Vegas, NV
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Oklahoma City, OK
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Altamonte Springs, FL
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Altamonte Springs, FL
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Little Rock, AR
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Jackson, MS
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Hershey, PA
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Hershey, PA
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Houston, TX
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Richmond, VA
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Atlanta, GA
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Investigator Site 302
mi
from
Torokbalint,
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Investigator Site 302
mi
from
Torokbalint,
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Denver, CO
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Miami, FL
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Iowa City, IA
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Wilmington, DE
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Wilmington, DE
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Ann Arbor, MI
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Kalamazoo, MI
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Dallas, TX
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Los Angeles, CA
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Orange, CA
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Portland, ME
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Portland, ME
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Durham, NC
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Jacksonville, FL
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Long Beach, CA
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Toledo, OH
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Cleveland, OH
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Louisville, KY
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Evaluating the Clinical Effectiveness of 3D Printing for a Patient-specific Silicone Stent Airway Implant
Small Feasibility Study for Evaluating the Clinical Effectiveness of 3D Printing for a Patient-specific Silicone Stent Airway Implant
Status: Enrolling
Updated:  3/6/2018
Cleveland Clinic
mi
from
Cleveland, OH
Evaluating the Clinical Effectiveness of 3D Printing for a Patient-specific Silicone Stent Airway Implant
Small Feasibility Study for Evaluating the Clinical Effectiveness of 3D Printing for a Patient-specific Silicone Stent Airway Implant
Status: Enrolling
Updated: 3/6/2018
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2
Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2
Status: Enrolling
Updated:  3/7/2018
Texas A&M University
mi
from
College Station, TX
Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2
Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2
Status: Enrolling
Updated: 3/7/2018
Texas A&M University
mi
from
College Station, TX
Click here to add this to my saved trials
Casein Protein and Leucine Supplementation in Chronic Obstructive Pulmonary Disease (COPD)
Casein Protein and Leucine Supplementation to Induce Anabolism in COPD Patients and Healthy Elderly
Status: Enrolling
Updated:  3/7/2018
Texas A&M University
mi
from
College Station, TX
Casein Protein and Leucine Supplementation in Chronic Obstructive Pulmonary Disease (COPD)
Casein Protein and Leucine Supplementation to Induce Anabolism in COPD Patients and Healthy Elderly
Status: Enrolling
Updated: 3/7/2018
Texas A&M University
mi
from
College Station, TX
Click here to add this to my saved trials
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis - A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects
Status: Enrolling
Updated:  3/7/2018
Dr Lawrence Sinde
mi
from
Mobile, AL
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis - A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects
Status: Enrolling
Updated: 3/7/2018
Dr Lawrence Sinde
mi
from
Mobile, AL
Click here to add this to my saved trials
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis - A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects
Status: Enrolling
Updated:  3/7/2018
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis - A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects
Status: Enrolling
Updated: 3/7/2018
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis - A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects
Status: Enrolling
Updated:  3/7/2018
Pediatric Pulmonology
mi
from
Long Beach, CA
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis - A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects
Status: Enrolling
Updated: 3/7/2018
Pediatric Pulmonology
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis - A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects
Status: Enrolling
Updated:  3/7/2018
University of CA, Davis
mi
from
Sacramento, CA
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis - A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects
Status: Enrolling
Updated: 3/7/2018
University of CA, Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis - A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects
Status: Enrolling
Updated:  3/7/2018
The Hartford Hospital
mi
from
Hartford, CT
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis - A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects
Status: Enrolling
Updated: 3/7/2018
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis - A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects
Status: Enrolling
Updated:  3/7/2018
Dr Mitchell Rothstein
mi
from
Jacksonville, FL
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis - A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects
Status: Enrolling
Updated: 3/7/2018
Dr Mitchell Rothstein
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis - A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects
Status: Enrolling
Updated:  3/7/2018
University of Miami
mi
from
Miami, FL
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis - A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects
Status: Enrolling
Updated: 3/7/2018
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials